Literature DB >> 8557350

Intracellular growth and cytotoxicity of Mycobacterium haemophilum in a human epithelial cell line (Hec-1-B).

L J Fischer1, F D Quinn, E H White, C H King.   

Abstract

We developed an in vitro model to study the temperature-regulated cytotoxicity and intracellular growth of Mycobacterium haemophilum in cultured human epithelial and endothelial cells. M. haemophilum associated with human epithelial and endothelial cells at similar rates when incubated at 33 and 37 degrees C, but only the epithelial cell line supported the multiplication of this organism. M. haemophilum grew equally well with epithelial cells at both temperatures. The aminoglycoside antibiotic amikacin was used to study the intracellular growth of M. haemophilum in the epithelial cells at 33 and 37 degrees C. Although an approximately equal number of bacteria were found within cells after 2 days of incubation at both temperatures, intracellular replication of M. haemophilum was 1,000-fold greater at 33 than at 37 degrees C. This intracellular multiplication was associated with destruction of the monolayers at 33 but not at 37 degrees C, and only culture filtrates from infected monolayers incubated at 33 degrees C were cytotoxic to fresh epithelial cell monolayers. This strain of M. haemophilum also produced contact-dependent hemolysis of sheep erythrocytes, demonstrating the possible presence of a cytolysin. These studies suggest that M. haemophilum has a preference for growth with cultured human epithelial cells. In addition, intracellular growth is best at 33 degrees C in epithelial cells, and this correlated with cytotoxicity at this temperature. This phenotype may be caused by induction of a soluble cytotoxic component, possibly a hemolytic cytolysin.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8557350      PMCID: PMC173755          DOI: 10.1128/iai.64.1.269-276.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  HMEC-1: establishment of an immortalized human microvascular endothelial cell line.

Authors:  E W Ades; F J Candal; R A Swerlick; V G George; S Summers; D C Bosse; T J Lawley
Journal:  J Invest Dermatol       Date:  1992-12       Impact factor: 8.551

2.  A tissue culture bilayer model to study the passage of Neisseria meningitidis.

Authors:  K A Birkness; B L Swisher; E H White; E G Long; E P Ewing; F D Quinn
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

3.  Varied presentations and responses to treatment of infections caused by Mycobacterium haemophilum in patients with AIDS.

Authors:  L L Dever; J W Martin; B Seaworth; J H Jorgensen
Journal:  Clin Infect Dis       Date:  1992-06       Impact factor: 9.079

4.  Mycobacterium marinum persists in cultured mammalian cells in a temperature-restricted fashion.

Authors:  L Ramakrishnan; S Falkow
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

Review 5.  Mycobacterium haemophilum: an emerging pathogen.

Authors:  T E Kiehn; M White
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

6.  Clinical and epidemiologic characteristics of Mycobacterium haemophilum, an emerging pathogen in immunocompromised patients.

Authors:  W L Straus; S M Ostroff; D B Jernigan; T E Kiehn; E M Sordillo; D Armstrong; N Boone; N Schneider; J O Kilburn; V A Silcox; V LaBombardi; R C Good
Journal:  Ann Intern Med       Date:  1994-01-15       Impact factor: 25.391

7.  Activities of antimicrobial agents against clinical isolates of Mycobacterium haemophilum.

Authors:  E M Bernard; F F Edwards; T E Kiehn; S T Brown; D Armstrong
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

8.  Expression of contact-dependent cytolytic activity by Mycobacterium tuberculosis and isolation of the genomic locus that encodes the activity.

Authors:  C H King; S Mundayoor; J T Crawford; T M Shinnick
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

9.  A cluster of four cases of Mycobacterium haemophilum infection.

Authors:  T E Kiehn; M White; K J Pursell; N Boone; M Tsivitis; A E Brown; B Polsky; D Armstrong
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-02       Impact factor: 3.267

Review 10.  Mycobacterium haemophilum infection in immunocompromised patients: case report and review of the literature.

Authors:  M Kristjansson; V M Bieluch; P D Byeff
Journal:  Rev Infect Dis       Date:  1991 Sep-Oct
View more
  13 in total

1.  Temporal pore formation-mediated egress from macrophages and alveolar epithelial cells by Legionella pneumophila.

Authors:  O A Alli; L Y Gao; L L Pedersen; S Zink; M Radulic; M Doric; Y Abu Kwaik
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

2.  Comparison of in vitro models for the study of Mycobacterium tuberculosis invasion and intracellular replication.

Authors:  P K Mehta; C H King; E H White; J J Murtagh; F D Quinn
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

3.  Observed differences in virulence-associated phenotypes between a human clinical isolate and a veterinary isolate of Mycobacterium avium.

Authors:  K A Birkness; W E Swords; P H Huang; E H White; C S Dezzutti; R B Lal; F D Quinn
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

4.  Optimal detection and identification of Mycobacterium haemophilum in specimens from pediatric patients with cervical lymphadenopathy.

Authors:  Z Samra; L Kaufmann; A Zeharia; S Ashkenazi; J Amir; J Bahar; U Reischl; L Naumann
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

5.  Infection with Mycobacterium ulcerans induces persistent inflammatory responses in mice.

Authors:  Martinha S Oliveira; Alexandra G Fraga; Egídio Torrado; António G Castro; João P Pereira; Adhemar Longatto Filho; Fernanda Milanezi; Fernando C Schmitt; Wayne M Meyers; Françoise Portaels; Manuel T Silva; Jorge Pedrosa
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

6.  Evidence for an intramacrophage growth phase of Mycobacterium ulcerans.

Authors:  Egídio Torrado; Alexandra G Fraga; António G Castro; Pieter Stragier; Wayne M Meyers; Françoise Portaels; Manuel T Silva; Jorge Pedrosa
Journal:  Infect Immun       Date:  2006-12-04       Impact factor: 3.441

7.  Mycobacterium ulcerans cytotoxicity in an adipose cell model.

Authors:  K M Dobos; P L Small; M Deslauriers; F D Quinn; C H King
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

Review 8.  Mycobacterium haemophilum: microbiology and expanding clinical and geographic spectra of disease in humans.

Authors:  M A Saubolle; T E Kiehn; M H White; M F Rudinsky; D Armstrong
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

9.  The Mycobacterium tuberculosis phagosome in human macrophages is isolated from the host cell cytoplasm.

Authors:  Daniel L Clemens; Bai-Yu Lee; Marcus A Horwitz
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

10.  Modulation of host ubiquitin system genes in human endometrial cell line infected with Mycobacterium tuberculosis.

Authors:  S Meenu; S Thiagarajan; Sudha Ramalingam; A Michael; Sankaran Ramalingam
Journal:  Med Microbiol Immunol       Date:  2015-09-24       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.